benzylamine has been researched along with thienopyrimidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjørkøy, G; Bugge, S; Hoff, BH; Kaspersen, SJ; Larsen, S; Nonstad, U; Sundby, E | 1 |
| Baek, DJ; Choo, H; Kim, M; Kim, Y; Park, KD; Park, M; Tae, J | 1 |
| Buene, AF; Bugge, S; Hoff, BH; Jurisch-Yaksi, N; Moen, IU; Skjønsfjell, EM; Sundby, E | 1 |
3 other study(ies) available for benzylamine and thienopyrimidine
| Article | Year |
|---|---|
Structure-activity study leading to identification of a highly active thienopyrimidine based EGFR inhibitor.
Topics: Antineoplastic Agents; Benzylamines; Cell Line, Tumor; ErbB Receptors; Humans; Models, Molecular; Neoplasms; Protein Kinase Inhibitors; Pyrimidines | 2014 |
Synthesis of novel dihydropyridothienopyrimidin-4,9-dione derivatives.
Topics: Benzylamines; Humans; Molecular Structure; Pyrimidines; Receptors, Metabotropic Glutamate | 2015 |
Extended structure-activity study of thienopyrimidine-based EGFR inhibitors with evaluation of drug-like properties.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Benzylamines; Drug Design; Drug Evaluation, Preclinical; Embryo, Nonmammalian; ErbB Receptors; Humans; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship; Toxicity Tests; Zebrafish | 2016 |